Pharmazone Competitors

Horizon Pharmacy is a logistics and supply chain company based out of 4027 Central Ave Ne, Columbia Heights, Minnesota, United States.

Galaxy Pharma was established in 2003 and today it is one of Pakistan's leading Pharmaceutical companies in the fields of Infertility, Gynecology, Oncology, Surgical/Orthopedic, Cosmetics/Aesthetics, Diabetes/Anesthesia. Another wing of group of companies started Nutraceuticals manufacturing also. The company stands as No. 1 for the Women’s Health care taking in from Nutraceuticals, Obstetrics & Gynecology to Infertility treatment products. The platform of Galaxy Pharma started off with its first project on infertility treatments and headed out expanding to a wide range of services from Oncology, Obstetrics & Gynecology, Nutraceuticals, Diagnostics and Surgical Management. The company is evolving from a marketing firm to a full blown manufacturing. A state of the art manufacturing facility is being developed in the middle of Korangi Creek Industrial Park. Company has started its Nutraceuticals manufacturing in 2022 and plans aggressively to expand it. Company also plans to launch its pilot production plant for pharma as soon as regulatory approvals are secured. Today, Galaxy has exclusive marketing and distribution rights in Pakistan from world's several leading multinational pharmaceutical companies. Galaxy Pharma’s marketing philosophy is to offer quality products that are bioequivalent to the leader - at prices that are affordable to a diverse cross-section of the community with a focus on scientific information dissemination. Being socially responsible and adding value to the medical community is an integral part of Galaxy’s philosophy. Galaxy Pharma’s marketing strategies are an ideal mix of public awareness campaigns, disease awareness and prevention campaigns, scientific promotion, and customer relationship management. Galaxy Pharma’s Vision is to be #1 in Healthcare sector.

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite’s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.